Study title:
AN 08532571 Medline 20070101.
TI Cyproheptadine-induced central anticholinergic syndrome in a child: a case report.
SO Pediatric emergency care, {Pediatr-Emerg-Care}, Aug 1995, vol. 11, no. 4, p. 235-7, ISSN: 0749-5161.
AU Blaustein-B-S, Gaeta-T-J, Balentine-J-R, Gindi-M. IN Department of Emergency Medicine, St. Barnabas Hospital, Bronx, New York 10457, USA. YR 1995.AN 08532571 Medline 20070101.
TI Cyproheptadine-induced central anticholinergic syndrome in a child: a case report.
SO Pediatric emergency care, {Pediatr-Emerg-Care}, Aug 1995, vol. 11, no. 4, p. 235-7, ISSN: 0749-5161.
AU Blaustein-B-S, Gaeta-T-J, Balentine-J-R, Gindi-M. IN Department of Emergency Medicine, St. Barnabas Hospital, Bronx, New York 10457, USA. YR 1995.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|